LENSAR (LNSR) Set to Post Quarterly Earnings on Tuesday

LENSAR (NASDAQ:LNSR) is expected to be issuing its Q3 2026 results before the market opens on Tuesday, November 10th. Analysts expect the company to announce earnings of ($0.0950) per share and revenue of $14.30 million for the quarter. Parties may review the information on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 8:30 AM ET.

LENSAR (NASDAQ:LNSR) last released its earnings results on Thursday, August 13th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.26. LENSAR had a negative return on equity of 529.08% and a net margin of 57.57%. The firm had revenue of $16.50 million for the quarter, compared to analyst estimates of $14.65 million.

LENSAR Stock Performance

Shares of LNSR opened at $5.45 on Monday. The stock has a market cap of $66.96 million, a P/E ratio of -16.52 and a beta of 1.03. LENSAR has a 1 year low of $4.95 and a 1 year high of $12.94. The stock’s 50-day moving average price is $6.78 and its two-hundred day moving average price is $7.36.

Analysts Set New Price Targets

A number of analysts recently weighed in on LNSR shares. BTIG Research increased their price target on shares of LENSAR from $9.00 to $10.00 and gave the company a “buy” rating in a research report on Thursday, August 20th. Weiss Ratings upgraded shares of LENSAR from a “sell (d)” rating to a “sell (d+)” rating in a report on Thursday, October 22nd. Wall Street Zen cut shares of LENSAR from a “buy” rating to a “hold” rating in a report on Saturday, October 3rd. Loop Capital set a $11.00 target price on shares of LENSAR in a research note on Monday, September 28th. Finally, Lake Street Capital reiterated a “buy” rating and issued a $13.00 target price on shares of LENSAR in a report on Thursday, August 13th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $11.33.

LENSAR Company Profile

LENSAR, Inc is a medical technology company focused on ophthalmic laser systems used in cataract surgery and other procedures involving the eye. The company develops and commercializes femtosecond laser technology designed to assist surgeons with key steps of cataract surgery, including corneal incisions, capsulotomy and lens fragmentation.

Its product portfolio includes the LENSAR Laser System, which incorporates image-guidance and planning technologies intended to support precise, customized procedures.